Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinical Trial Enrollment

ABPI London offices

ABPI pledges greater payment transparency

UK pharma trade body updates Code of Practice

- PMLiVE

Sarepta slumps as FDA questions muscular dystrophy drug

US regulator casts doubt on biomarker for eteplirsen

Hollingsworth leaves cancer charity for ABPI

Andrew Hollingsworth appointed policy manager at pharma industry body

- PMLiVE

New US guidelines to boost statin use but Crestor may miss out

American Heart Association and American College of Cardiology put emphasis on patient characteristics

Pfizer finally acquires the @pfizer name on Twitter

Will streamline its existing @pfizer_news account

- PMLiVE

GSK hit as darapladib flunks phase III test

Heart disease drug disappoints in late-stage trial

Deal Watch table for October 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Pharma deals during October 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

ProStrakan lines up new chairman for 2014

Dr John Brown will replace Peter Allen

- PMLiVE

Scotland first in UK to back Pfizer’s Inlyta

SMC also recommends Astellas' Xtandi but not Pfizer's Bosulif

National Institute for Health and Care Excellence NICE logo

NICE denies early use of Janssen’s Velcade

Draft guidance doesn't recommend expanded bone marrow cancer indication

- PMLiVE

Mobile health apps – still a novelty?

There are thousands of mobile health apps, but they've yet to live up to their potential

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links